MTOR and breast cancer: Based on advances in the understanding of muscle-cancer cross talk, we hypothesized that pharmacologically active signaling factors released from contracting skeletal muscle would suppress anabolism in cultured MCF7 breast cancer cells by acting on the anabolic mTOR axis.